Therapeutic Advances in Psychopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.0 | Q1 | 86.5% | 1.321 | Q1 | 89.9% |
| 2024 | 4.0 | Q1 | 81.6% | 1.187 | Q1 | 88.2% |
| 2023 | 3.4 | Q2 | 70.1% | 1.179 | Q1 | 89.0% |
| 2022 | 4.2 | Q2 | 70.9% | — | 0.0% | |
| 2021 | 5.0 | Q2 | 76.0% | — | 0.0% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2045-1253
ISSN
2045-1261
country
GBcoverage
2011-2026